Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Capital Llc Orbimed currently holds 83,695 shares of Arcutis Biotherapeutics, Inc. (ARQT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Llc Orbimed has been a net buyer of ARQT stock. They have purchased $54.8M and sold $39.4M worth of shares.
Capital Llc Orbimed's most recent insider trade was on Aug 26, 2024, when they sold 83,695 shares at $13.00 per share.
Capital Llc Orbimed serves as Executive at Arcutis Biotherapeutics, Inc. (ARQT). They have executed 49 insider transactions totaling $94.2M over their tenure at the company.
Capital Llc Orbimed holds the position of Executive at Arcutis Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Capital Llc Orbimed has shown a buying trading pattern, with $54.8M in total purchases and $39.4M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Capital Llc Orbimed was on Jul 1, 2022, when they sold $83.1M worth of SRRA shares. This transaction involved 1,511,362 shares at $55.00 per share.
Capital Llc Orbimed currently owns 83,695 shares of Arcutis Biotherapeutics, Inc. (ARQT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Capital Llc Orbimed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Capital Llc Orbimed has 49 Form 4 filings on record as an insider at Arcutis Biotherapeutics, Inc..
Set alerts for Capital Llc Orbimed and 40,000+ other insiders.